VURAL, A. Et Al. 2023. The impact of radioactive iodine treatment on subclinical left ventricular dysfunction in patients treated for differentiated thyroid cancer: assessing the predictive value of presystolic wave. The European Research Journal , vol.9, no.2 , 200-206.

VURAL, A., DİKBAŞ, O., VURAL, S., Bozoglan, H., & SÖNMEZ, B., (2023). The impact of radioactive iodine treatment on subclinical left ventricular dysfunction in patients treated for differentiated thyroid cancer: assessing the predictive value of presystolic wave. The European Research Journal , vol.9, no.2, 200-206.

VURAL, ASLI Et Al. "The impact of radioactive iodine treatment on subclinical left ventricular dysfunction in patients treated for differentiated thyroid cancer: assessing the predictive value of presystolic wave," The European Research Journal , vol.9, no.2, 200-206, 2023

VURAL, ASLI Et Al. "The impact of radioactive iodine treatment on subclinical left ventricular dysfunction in patients treated for differentiated thyroid cancer: assessing the predictive value of presystolic wave." The European Research Journal , vol.9, no.2, pp.200-206, 2023

VURAL, A. Et Al. (2023) . "The impact of radioactive iodine treatment on subclinical left ventricular dysfunction in patients treated for differentiated thyroid cancer: assessing the predictive value of presystolic wave." The European Research Journal , vol.9, no.2, pp.200-206.

@article{article, author={ASLI VURAL Et Al. }, title={The impact of radioactive iodine treatment on subclinical left ventricular dysfunction in patients treated for differentiated thyroid cancer: assessing the predictive value of presystolic wave}, journal={The European Research Journal}, year=2023, pages={200-206} }